Point72 Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-87,190
| Closed | -$903K | – | 1402 |
|
|
2024
Q3 | $903K | Buy |
+87,190
| New | +$903K | ﹤0.01% | 861 |
|
|
2023
Q4 | – | Sell |
-25,932
| Closed | -$290K | – | 1567 |
|
|
2023
Q3 | $290K | Buy |
25,932
+17,732
| +216% | +$198K | ﹤0.01% | 1081 |
|
|
2023
Q2 | $175K | Sell |
8,200
-3,768
| -31% | -$80.6K | ﹤0.01% | 981 |
|
|
2023
Q1 | $484K | Buy |
+11,968
| New | +$484K | ﹤0.01% | 937 |
|
|
2022
Q3 | – | Sell |
-28,700
| Closed | -$1.36M | – | 1123 |
|
|
2022
Q2 | $1.36M | Buy |
+28,700
| New | +$1.36M | 0.01% | 807 |
|
|
2019
Q3 | – | Sell |
-400
| Closed | -$34K | – | 1134 |
|
|
2019
Q2 | $34K | Buy |
+400
| New | +$34K | ﹤0.01% | 1120 |
|
|
2018
Q4 | – | Sell |
-8,400
| Closed | -$718K | – | 909 |
|
|
2018
Q3 | $718K | Buy |
+8,400
| New | +$718K | ﹤0.01% | 736 |
|
|
2017
Q2 | – | Sell |
-56,200
| Closed | -$1.73M | – | 758 |
|
|
2017
Q1 | $1.73M | Buy |
+56,200
| New | +$1.73M | 0.01% | 610 |
|